A vasoprotective agent
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Tribenoside

Item No. 33498

Technical Information
Formal Name
ethyl 3,5,6-tris-O-(phenylmethyl)-D-glucofuranoside
CAS Number
10310-32-4
Molecular Formula
C29H34O6
Formula Weight
Purity
≥95% (mixture of anomers)
A neat oil
DMF: 30 mg/mlDMSO: 30 mg/mlEthanol: 30 mg/ml
SMILES
O[C@H]([C@H]1OCC2=CC=CC=C2)C(OCC)O[C@]1([H])[C@@H](COCC3=CC=CC=C3)OCC4=CC=CC=C4
InChi Code
InChI=1S/C29H34O6/c1-2-32-29-26(30)28(34-20-24-16-10-5-11-17-24)27(35-29)25(33-19-23-14-8-4-9-15-23)21-31-18-22-12-6-3-7-13-22/h3-17,25-30H,2,18-21H2,1H3/t25-,26-,27-,28-,29?/m1/s1
InChi Key
ULLNJSBQMBKOJH-VIVFLBMVSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Tribenoside is a vasoprotective agent with anti-allergic and anti-inflammatory activities.1,2 It inhibits agonist-induced contractions in various isolated porcine venous preparations when used at concentrations ranging from 10 to 30 µg/ml.1 Tribenoside inhibits compound 48/80-induced histamine release in isolated rat peritoneal cells (EC50 = 10 µg/ml).3 It reduces decreases in proteoglycan levels and the severity of cartilage destruction in the inflamed joints in a rabbit model of surgically induced osteoarthritis when administered at doses of 100 and 200 mg/kg per day.4 Formulations containing tribenoside have been used in the treatment of hemorrhoids and varicose veins.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Jaques, R. The activity pattern, in isolated veins, of a benzyl glucofuranoside derivative possessing combined anti-inflammatory and venotropic effects. Pharmacology 4(4), 193-202 (1970).

    2. Jaques, R. The pharmacological activity of tribenoside. Pharmacology 15(5), 445-460 (1977).

    3. Rüegg, M., and Jaques, R. Tribenoside as an inhibitor of chemically induced histamine release. Experientia 30(4), 399-401 (1974).

    4. Colombo, C., Butler, M., Hickman, L., et alA new model of osteoarthritis in rabbits. II. Evaluation of anti-osteoarthritic effects of selected antirheumatic drugs administered systemically. Arthritis Rheum. 26(9), 1132-1139 (1983).